Wednesday, 2 January 2019

FDA OKs Portola's new manufacturing process for Andexxa - Seeking Alpha

FDA OKs Portola's new manufacturing process for Andexxa  Seeking Alpha

The FDA approves Portola Pharmaceuticals' (PTLA -3.2%) application for its next-generation manufacturing process for anticoagulation reversal agent Andexxa ...

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)